Kezar Life Sciences, Inc.

NASDAQ (USD): Kezar Life Sciences, Inc. (KZR)

Last Price

6.52

Today's Change

+0.23 (3.65%)

Day's Change

6.16 - 6.67

Trading Volume

78,389

Overview

Market Cap

47 Million

Shares Outstanding

7 Million

Avg Volume

106,585

Avg Price (50 Days)

7.52

Avg Price (200 Days)

7.23

PE Ratio

-0.50

EPS

-13.12

Earnings Announcement

12-Mar-2025

Previous Close

6.29

Open

6.26

Day's Range

6.16 - 6.6788

Year Range

5.2 - 11.4

Trading Volume

78,389

Price Change Highlight

1 Day Change

3.66%

5 Day Change

-3.98%

1 Month Change

-11.65%

3 Month Change

11.84%

6 Month Change

-1.51%

Ytd Change

-31.37%

1 Year Change

-23.65%

3 Year Change

-95.58%

5 Year Change

-79.75%

10 Year Change

-96.33%

Max Change

-96.33%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment